Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Indonesia Energy Corporation Limited — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Indonesia Energy Corporation Limited trades at $2.74 (market cap $43.24M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 290.9× Indonesia Energy Corporation Limited's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Indonesia Energy Corporation Limited for 24 Days on average.
| HALO | INDO | |
|---|---|---|
Market Cap | $12.58B | $43.24M |
Volume | 2,179,278 | 116,953 |
Sector | Health | Energy |
52-Week High | $115.22 | $6.74 |
52-Week Low | $61.63 | $2.49 |
Typical Hold Time | 1 Days | 24 Days |
Enterprise Value | $14.49B | $38.18M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INDO trades at $2.81, up 1.44% on the day, but exhibits a bearish technical signal with negative profitability metrics including a net income margin of -152.72% and ROE of -19.77% for 2025. Recent news highlights operational progress with the K-29 oil well discovery and production commencement, though financial results remain deeply negative. The stock's price-to-sales ratio is elevated at 15.2, and cash flow from operations is negative at -$5.43M, offset by financing inflows.
The outlook is speculative, hinging on successful production scaling from new wells to reverse persistent losses. Investment opportunity lies in potential revenue growth from oil operations, but risks include high cash burn, negative margins, and execution challenges in a volatile energy market. Analyst consensus is unanimously bullish with 3 buy ratings, suggesting optimism on future turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
